Herpes zoster subunit vaccine for patients initiating a Janus kinase inhibitorJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82023-03-012OA
Letter in Reply: Promoting accurate public health messages about electronic cigarettes: E-cigs contain carcinogensJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82023-01-011OAAI
Melanoma: An update on systemic therapiesJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82022-03-0139PRE
Melanoma: How and when to consider clinical diagnostic technologiesJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82022-03-018PRE
Residency applicant photographs: Why do we ask for them?JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82022-02-010OAAI
Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communicationJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82022-01-0112PRE
Dupilumab Facial Redness/Dupilumab Facial Dermatitis: A Guide for CliniciansAMERICAN JOURNAL OF CLINICAL DERMATOLOGYIF8.82021-12-0220PRE
Dermatology patients on biologics and certain other systemic therapies should receive a booster'' messenger RNA COVID-19 vaccine dose: A critical appraisal of recent Food and Drug Administration and Advisory Committee on Immunization Practices recommendationsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-11-0111OAAI
Reply to: Metformin use and keratinocyte carcinoma riskJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-10-010OAAI
What makes a good'' case report? Examining factors affecting case report citationsJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-09-010PREAI
Consensus recommendations for the use of noninvasive melanoma detection techniques based on results of an international Delphi processJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-09-013OAAI
Laboratory monitoring requirements during mycophenolate mofetil therapy for dermatologic conditions: A single-institution retrospective chart reviewJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-09-010OAAI
Letter in reply: Understanding pregnancy risk and contraception options for transmasculine individuals on gender-affirming testosterone therapyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-09-011PRE
Metformin is associated with decreased risk of basal cell carcinoma: A whole-population case-control study from IcelandJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-07-0113PREAI
Anti-tumor necrosis factor therapy is associated with increased in situ squamous cell carcinoma of the skin: A population-based case-control studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-06-013PRE
Invasive and in situ squamous cell carcinoma of the skin: a nationwide study in IcelandBRITISH JOURNAL OF DERMATOLOGYIF9.62021-05-0912PREAI
Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximabJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-04-0115OAAI
Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control studyJOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGYIF11.82021-03-0129PREAI